Literature DB >> 10655425

Will there be resistance to the RECIST (Response Evaluation Criteria in Solid Tumors)?

E A Gehan, M C Tefft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10655425     DOI： 10.1093/jnci/92.3.179

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  33 in total

1.  A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.

Authors:  Christy Y Chai; Jeremiah L Deneve; Georgia M Beasley; Suroosh S Marzban; Y Ann Chen; Bhupendra Rawal; Stephen R Grobmyer; Steven N Hochwald; Douglas S Tyler; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2011-12-06       Impact factor: 5.344

2.  Can paediatric radiologists resist RECIST (response evaluation criteria in solid tumours)?

Authors:  Kieran McHugh; Simon Kao
Journal:  Pediatr Radiol       Date:  2003-11

3.  Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: a Hellenic Cooperative Oncology Group Phase II Study.

Authors:  George Fountzilas; Christos Tolis; Anna Kalogera-Fountzila; Despina Misailidou; Periklis Tsekeris; Maria Karina; Angelos Nikolaou; Epaminondas Samantas; Thomas Makatsoris; Eleni Athanassiou; Dimosthenis Skarlos; Aristotelis Bamias; Nikolas Zamboglou; Theofanis Economopoulos; Sophia Karanastassi; Nicholas Pavlidis; John Daniilidis
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

Review 4.  A review of the automated detection of change in serial imaging studies of the brain.

Authors:  Julia Patriarche; Bradley Erickson
Journal:  J Digit Imaging       Date:  2004-06-29       Impact factor: 4.056

5.  Part 1. Automated change detection and characterization in serial MR studies of brain-tumor patients.

Authors:  Julia Willamena Patriarche; Bradley James Erickson
Journal:  J Digit Imaging       Date:  2007-09       Impact factor: 4.056

6.  PET imaging for Treatment Response in Cancer.

Authors:  Janet F Eary
Journal:  PET Clin       Date:  2008-01-01

7.  Treatment response classification of liver metastatic disease evaluated on imaging. Are RECIST unidimensional measurements accurate?

Authors:  Michael Mantatzis; Stylianos Kakolyris; Kyriakos Amarantidis; Anastasios Karayiannakis; Panos Prassopoulos
Journal:  Eur Radiol       Date:  2009-02-24       Impact factor: 5.315

8.  Successful use of metronomic vinblastine and fluorothymidine pet imaging for the management of intramedullary spinal cord anaplastic oligoastrocytoma in a child.

Authors:  R Demlova; K Melicharkova; Z Rehak; L Kren; H Oslejskova; J Sterba
Journal:  Curr Oncol       Date:  2014-12       Impact factor: 3.677

9.  A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors.

Authors:  Bhuvaneswari Ramaswamy; Tanios Bekaii-Saab; Larry J Schaaf; Gregory B Lesinski; David M Lucas; Donn C Young; Amy S Ruppert; John C Byrd; Kristy Culler; Diedre Wilkins; John J Wright; Michael R Grever; Charles L Shapiro
Journal:  Cancer Chemother Pharmacol       Date:  2009-09-23       Impact factor: 3.333

10.  Concomitant radiochemotherapy vs radiotherapy alone in patients with head and neck cancer: a Hellenic Cooperative Oncology Group Phase III Study.

Authors:  George Fountzilas; Elisabeta Ciuleanu; Urania Dafni; George Plataniotis; Anna Kalogera-Fountzila; Epaminontas Samantas; Eleni Athanassiou; John Tzitzikas; Tudor Ciuleanu; Angelos Nikolaou; Panayiotis Pantelakos; Thomas Zaraboukas; Nikolaos Zamboglou; John Daniilidis; Nicolas Ghilezan
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.